C000222149 Fees and Costs — Regan Total Return Income Fund, Institutional Class
Data updated: 2024-02-29
The net expense ratio is 1.31%: a 0.89% management fee plus 0.51% other expenses, less a 0.10% fee waiver. There are no sales loads or redemption fees. Portfolio turnover was 63%.
C000222149 Fees and Expenses
Annual operating expenses and sales charges of C000222149. Prospectus, as of January 31, 2023.
| Annual operating expenses | |
|---|---|
| Management fee | 0.89% |
| 12b-1 fee | 0.00% |
| Other expenses | 0.51% |
| Gross expense ratio | 1.41% |
| Fee waiver | −0.10% |
| Net expense ratio | 1.31% |
| Sales charges | |
|---|---|
| Max front load | — |
| Max deferred load | — |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | Yes |
| Fees waived or reduced during the year | Yes |
| Waived fees subject to recoupment | Yes |
C000222149 Costs Over Time
On $10,000 invested in C000222149, assuming 5% a year before costs, total costs come to $814 over 5 years, cutting the return by 1.38% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Fund expenses (net expense ratio 1.31%) | $138 | $428 | $739 |
| Lost growth on money paid in costs | $0 | $21 | $75 |
| Total costs | $138 | $449 | $814 |
| Value after costs | $10,362 | $11,127 | $11,948 |
| Impact on return, per year | 1.38% | 1.38% | 1.38% |
C000222149 Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending September 30, 2023.
- Explicit cost rate (commissions ÷ average net assets): —
- Total broker commissions: —
- Bought from dealers (principal trades, not a cost): —
- Portfolio turnover (prospectus): 63%
- Securities lending: none during the year
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.